Guardian Asset Advisors LLC Has $231,000 Stock Holdings in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Guardian Asset Advisors LLC trimmed its holdings in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 4.3% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 3,514 shares of the company’s stock after selling 157 shares during the period. Guardian Asset Advisors LLC’s holdings in iShares U.S. Pharmaceuticals ETF were worth $231,000 as of its most recent filing with the SEC.

Several other institutional investors have also made changes to their positions in the business. Pallas Capital Advisors LLC bought a new position in shares of iShares U.S. Pharmaceuticals ETF during the fourth quarter valued at $3,829,000. Southern Capital Advisors LLC increased its holdings in shares of iShares U.S. Pharmaceuticals ETF by 1.1% during the third quarter. Southern Capital Advisors LLC now owns 40,280 shares of the company’s stock worth $2,844,000 after buying an additional 448 shares in the last quarter. Thrivent Financial for Lutherans raised its stake in shares of iShares U.S. Pharmaceuticals ETF by 23.6% in the third quarter. Thrivent Financial for Lutherans now owns 32,509 shares of the company’s stock valued at $2,295,000 after acquiring an additional 6,214 shares during the last quarter. Patten & Patten Inc. TN raised its stake in shares of iShares U.S. Pharmaceuticals ETF by 9.5% in the third quarter. Patten & Patten Inc. TN now owns 25,813 shares of the company’s stock valued at $1,823,000 after acquiring an additional 2,245 shares during the last quarter. Finally, Strategic Financial Concepts LLC acquired a new position in shares of iShares U.S. Pharmaceuticals ETF in the 4th quarter worth approximately $1,312,000.

iShares U.S. Pharmaceuticals ETF Price Performance

IHE stock opened at $70.90 on Friday. The business has a fifty day moving average price of $67.43 and a 200 day moving average price of $69.14. iShares U.S. Pharmaceuticals ETF has a fifty-two week low of $62.67 and a fifty-two week high of $72.94. The stock has a market capitalization of $716.09 million, a price-to-earnings ratio of 6.49 and a beta of 0.58.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.